Nov Hisse

Nov EBITDA

Nov (NOV) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 13 Ağu 2026 itibarıyla 564,00 M USD dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) 876,00 M USD idi — -35,62% (daha düşük) bir değişiklik.

EBITDA

564,00 MUSD

YoY

-35,62%

Son güncelleme:

Nov öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 564,00 M USD dir. Nov öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 876,00 M USD idi. %-35,62 daha düşük önceki yıla kıyasla azalmaktadır.
Access this data via the Eulerpool API

Nov Hisse senedi analizi

Nov ne yapar? Nov Inc is a globally operating company that was founded in the USA in 1976. The company specializes in the development and manufacture of products in various fields, including pharmaceuticals, biotechnology, agrochemicals, and electronics. Nov Inc's business model is based on the research and development of new technologies and products. The company invests a significant portion of its resources in the research and development of new drugs and technologies. Nov Inc works closely with scientific organizations and universities to achieve this. The goal of Nov Inc is to develop products that have a positive impact on health, science, and the environment. The company aims to improve the quality of life for people worldwide by developing innovative products that meet the needs of its customers. Nov Inc is divided into several divisions. The main divisions are pharmaceuticals, biotechnology, diagnostics, crop protection, and electronics. In each of these divisions, the company produces products tailored to the needs of its customers. In the pharmaceutical field, Nov Inc develops and produces drugs for the treatment of various diseases such as cancer, diabetes, and cardiovascular diseases. Nov Inc's products are well-known worldwide and are taken by millions of patients every day. The company is proud to make a significant contribution to improving the health of people worldwide. In the biotechnology division, Nov Inc develops products for use in agriculture and environmental protection. This includes improved seed varieties that are more resistant to insects and diseases, thus reducing the use of pesticides. Nov Inc also produces biological pesticides that protect plants from pests while being non-toxic and environmentally friendly. In the diagnostics division, Nov Inc develops and produces tests for the diagnosis of infectious diseases and other medical conditions. These tests are important for the timely detection of diseases and enable early treatment. In the electronics division, Nov Inc develops and produces electronic devices and components. This includes semiconductors, sensors, and displays. These components are used in various industries, including telecommunications, automotive, and aerospace. In addition to the above-mentioned divisions, Nov Inc also offers other products, including food additives, colorants, fragrances, and chemicals for industrial use. Overall, Nov Inc has made a significant contribution to improving health, science, and the environment over the past decades. The company is globally recognized for its innovative products and technologies and will remain an important player in research and development in the future. Nov, Eulerpool'daki en popüler şirketlerden biridir.

Nov hisse senedi hakkında sık sorulan sorular

Nov şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında 564,00 M USD.

Nov öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 876,00 M USD değerinden 564,00 M USD değerine değişmiş ve bu %-35,62 değişimi temsil etmektedir. Değer önceki yıldan daha düşük dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Nov değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin USD, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Nov değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Nov

Tüm Kilit Metrikler — Nov